Adelson Medical Research Foundation Funds International
Collaborations in Cancer and Neurology
Foundation's Open and Highly Integrated Collaborative Model Brings
Together Multi-Disciplinary, Multi-Institutional Scientific Teams to
Address Major Unmet Medical Needs in Melanoma, Ovarian Cancer, and
NEEDHAM, MA -- (Marketwire) -- 11/01/12 -- The Dr. Miriam and
Sheldon G. Adelson Medical Research Foundation (AMRF), a private
foundation funding collaborative translational science, announced
today a new round of funding for global research programs in cancer
and neurological disease. AMRF has just funded 13 collaborations
involving 96 interacting projects. These two-year awards will help
support 58 biomedical researchers conducting translational research
in oncology and neurology at 32 leading academic institutions in the
U.S. and Israel.
"Our foundation emphasizes research that is intended to have a
significant impact on patient care in a reasonable period of time,"
said Dr. Miriam Adelson, Trustee of the Foundation. Dr. Adelson is a
dedicated physician-scientist who oversees clinics for the treatment
of addictive diseases in Las Vegas and Tel Aviv. "AMRF encourages
teams of renowned scientists across multiple disciplines and
institutions to pursue significant new research goals rather than
incremental progress," noted Sheldon G. Adelson, Trustee of the
Foundation and Chairman of the Board and Chief Executive Officer of
Las Vegas Sands Corp.
"The foundation's updated research programs will explore the leading
edge of translational research in melanoma, ovarian cancer, and
neural repair for treating stroke, spinal cord injury and
neuropathy," explained Dr. Kenneth H. Fasman, Vice President and
Chief Scientific Officer of AMRF. "Our collaborating teams of
scientists and clinicians, supported by state-of-the-art platforms
for genomics, proteomics, epigenomics, and informatics, are able to
pursue high-risk, high-reward research strategies that are difficult
to get backing for via more conventional funding programs."
"The Adelson Medical Research Foundation has developed a creative
model that fosters collaboration over competition in important areas
of biomedical research," stated Aaron Ciechanover, M.D., D.Sc.,
Distinguished Research Professor at the Technion - Israel Institute
of Technology's Ruth and Bruce Rappaport Faculty of Medicine. Dr.
Ciechanover, a 2004 Nobel Laureate in Chemistry, co-directs AMRF's
Program in Cancer Research. "The support provided by the foundation
is truly unique, as it stems from an intensely collaborative set of
interactions among leading scientists towards a goal of initiating
breakthrough studies of brain, spinal cord and nerve repair," added
S. Thomas Carmichael, M.D., Ph.D., Professor and Vice Chair for
Research and Programs in the Department of Neurology at UCLA's Geffen
School of Medicine. Dr. Carmichael leads AMRF's Program in Neural
Repair and Rehabilitation.
The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation,
established in 2006, is a private foundation committed to a model of
open and highly integrated collaboration among outstanding
investigators who participate in goal-directed basic and clinical
research to prevent, reduce or eliminate disabling and
life-threatening illness. The Foundation creates a culture of
scientific discovery, evaluation, and clinical application directed
by the experiences of scientists who are not bound by searching for
the cure of any single disease. Programs within the Foundation are
defined in broad terms. The Adelson Program in Cancer Research
pursues therapies targeted to the mechanisms that make cells
malignant, and the Adelson Program in Neural Repair and
Rehabilitation seeks to manipulate the regeneration of neurons in the
brain, spinal cord and periphery.
For additional information on the Dr. Miriam and Sheldon G. Adelson
Medical Research Foundation, please visit
Contracts and Special Projects Manager
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Press spacebar to pause and continue. Press esc to stop.